Recruiting
Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation
About this study
The purpose of this research study is to document and understand the effects of hydroxyurea exposure for women with SCD and their babies, during both gestation and lactation.
- Condition
- Sickle Cell Disease, Sickle Cell Anemia
- Tested
- Chart Review, Survey
- Sponsor
- Children's Hospital Medical Center, Cincinnati
Who can join
- Age
- Not specified
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 3
- Study condition: Sickle Cell Disease, Sickle Cell Anemia
- Medical records or data available from previous clinical care prior to June 20, 2019 of pregnant females with SCD, including women who miscarried, had a still birth, or completed labor at any gestational stage, with any hydroxyurea exposure during either pregnancy and/or while breastfeeding.
- Medical records or data available from previous clinical care prior to June 20, 2019 about pregnancy and breastfeeding outcomes, both for babies with hydroxyurea exposure and other babies by these same women.
Exclusion 1
- Unavailable medical records or lack of information about hydroxyurea exposure.
Where
1 site, 1 recruiting
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Contact
-
Teresa Latham
513-803-7922 Teresa.Latham@cchmc.org
Potential match only. Final eligibility is determined by the study team.